2,466
Views
16
CrossRef citations to date
0
Altmetric
Original Articles

Bone cement product and failure in total knee arthroplasty

A follow-up study of 26,147 knee replacements between 1997 and 2013 in Norway

, , &
Pages 75-81 | Received 27 Jan 2016, Accepted 04 Aug 2016, Published online: 14 Nov 2016

  • Bridgens J, Davies S, Tilley L, Norman P, Stockley I. Orthopaedic bone cement: do we know what we are using? J Bone Joint Surg (Br) 2008; 90 (5): 643–7.
  • Carr A J, Robertsson O, Graves S, Price A J, Arden N K, Judge A, Beard D J. Knee replacement. Lancet 2012; 379 (9823): 1331–40.
  • Dale H, Hallan G, Hallan G, Espehaug B, Havelin L I, Engesaeter L B. Increasing risk of revision due to deep infection after hip arthroplasty. Acta Orthop 2009; 80 (6): 639–45.
  • Dale H, Fenstad A M, Hallan G, Havelin L I, Furnes O, Overgaard S, Pedersen A B, Karrholm J, Garellick G, Pulkkinen P, Eskelinen A, Makela K, Engesaeter L B. Increasing risk of prosthetic joint infection after total hip arthroplasty. Acta Orthop 2012; 83 (5): 449–58.
  • Dall G F, Simpson P M, Breusch S J. In vitro comparison of Refobacin-Palacos R with Refobacin Bone Cement and Palacos R + G. Acta Orthop 2007a; 78 (3): 404–11.
  • Dall G F, Simpson P M, Mackenzie S P, Breusch S J. Inter- and intra-batch variability in the handling characteristics and viscosity of commonly used antibiotic-loaded bone cements. Acta Orthop 2007b; 78 (3): 412–20.
  • Espehaug B, Engesaeter L B, Vollset S E, Havelin L I, Langeland N. Antibiotic prophylaxis in total hip arthroplasty. Review of 10,905 primary cemented total hip replacements reported to the Norwegian arthroplasty register, 1987 to 1995. J Bone Joint Surg Br 1997; 79 (4): 590–5.
  • Espehaug B, Furnes O, Havelin L I, Engesaeter L B, Vollset S E. The type of cement and failure of total hip replacements. J Bone Joint Surg Br 2002; 84 (6): 832–8.
  • Espehaug B, Furnes O, Havelin L I, Engesaeter L B, Vollset S E, Kindseth O. Registration completeness in the Norwegian Arthroplasty Register. Acta Orthop 2006; 77 (1): 49–56.
  • Furnes O, Lie S A, Havelin L I, Vollset S E, Engesaeter L B. Exeter and Charnley arthroplasties with Boneloc or high viscosity cement. Comparison of 1,127 arthroplasties followed for 5 years in the Norwegian Arthroplasty Register. Acta Orthop Scand 1997; 68 (6): 515–20.
  • Furnes O, Espehaug B, Lie S A, Vollset S E, Engesaeter L B, Havelin L I. Early failures among 7,174 primary total knee replacements: a follow-up study from the Norwegian Arthroplasty Register 1994-2000. Acta Orthop Scand 2002; 73 (2): 117–29.
  • Furnes O, Baste V, Krukhaug Y, Kvinnesland I A. Annual report for the Norwegian Arthroplasty Register 2014. Helse Bergen HF, Bergen 2014.
  • Havelin L I, Espehaug B, Vollset S E, Engesaeter L B. The effect of the type of cement on early revision of Charnley total hip prostheses. A review of eight thousand five hundred and seventy-nine primary arthroplasties from the Norwegian Arthroplasty Register. J Bone Joint Surg (Am) 1995; 77 (10): 1543–50.
  • Havelin L I, Engesaeter L B, Espehaug B, Furnes O, Lie S A, Vollset S E. The Norwegian Arthroplasty Register: 11 years and 73,000 arthroplasties. Acta Orthop Scand 2000; 71 (4): 337–53.
  • Kock H J, Huber F X, Hillmeier J, Jager R, Volkmann R, Handschin A E, Letsch R, Meeder P J. In vitro studies on various PMMA bone cements: a first comparison of new materials for arthroplasty. Z Orthop Unfall 2008; 146 (1): 108–13.
  • KOFA. The Norwegian Complaints Board for Public Procurement - case 2010/211; 2011 [cited 2015 10.10]. Available from: http://www.kofa.no.
  • Kühn K-D. Bone cements. Up-to-date comparison of physical and chemical properties of commercial materials. Springer-Verlag, Berlin 2000.
  • Labek G, Schöffl H, Meglic M. New Medical Device Regulations ahead – What does that mean for Arthroplasty Registers? Acta Orthop 2015; 86 (1): 5–6.
  • Markel D C, Hoard D B, Porretta C A. Cemented total hip arthroplasty with Boneloc bone cement. J South Orthop Assoc 2001; 10 (4): 202–8.
  • Milner R. The development of theoretical relationships between some handling parameters (setting time and setting temperature), composition (relative amounts of initiator and activator) and ambient temperature for acrylic bone cement. J Biomed Mater Res B Appl Biomater 2004; 68 (2): 180–5.
  • Neut D, Kluin O S, Thompson J, van der Mei H C, Busscher H J. Gentamicin release from commercially-available gentamicin-loaded PMMA bone cements in a prosthesis-related interfacial gap model and their antibacterial efficacy. BMC Musculoskelet Disord 2010; 11: 258.
  • Nottrott M. Acrylic bone cements: influence of time and environment on physical properties. Acta Orthop Suppl 2010; 81 (341): 1–27.
  • Olerud F, Olsson C, Flivik G. Comparison of Refobacin bone cement and palacos with gentamicin in total hip arthroplasty: an RSA study with two years follow-up. Hip Int 2014; 24 (1): 56–62.
  • Ranstam J, Kärrholm J, Pulkkinen P, Mäkelä K, Espehaug B, Pedersen A B, Mehnert F, Furnes O. Statistical analysis of arthroplasty data. Acta Orthop 2011; 82 (3): 258–67.
  • Riehmann M. Regulatory measures for implementing new medical devices. Recalling Boneloc. Dan Med Bull 2005; 52 (1): 11–7.
  • Robertsson O, Bizjajeva S, Fenstad A M, Furnes O, Lidgren L, Mehnert F, Odgaard A, Pedersen A B, Havelin L I. Knee arthroplasty in Denmark, Norway and Sweden. A pilot study from the Nordic Arthroplasty Register Association. Acta Orthop 2010; 81 (1): 82–9.
  • Suominen S. Early failure with Boneloc bone cement. 4/8 femoral stems loose within 3 years. Acta Orthop Scand 1995; 66 (1): 13.
  • TaxAdmin. This is the National Registry. Tax administration Norway; 2014 [cited 2014 11.6]. Available from: http://www.skatteetaten.no/en/Person/National-Registry/This-is-the-National-Registry/.
  • Thanner J, Freij-Larsson C, Karrholm J, Malchau H, Wesslen B. Evaluation of Boneloc. Chemical and mechanical properties, and a randomized clinical study of 30 total hip arthroplasties. Acta Orthop Scand 1995; 66 (3): 207–14.
  • Tsukayama D T, Estrada R, Gustilo R B. Infection after total hip arthroplasty. A study of the treatment of one hundred and six infections. J Bone Joint Surg Am 1996; 78 (4): 512–23.